MedPath
FDA Approval

Midazolam Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Major Pharmaceuticals
DUNS: 191427277
Effective Date
April 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Midazolam(2 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Midazolam Hydrochloride

Product Details

NDC Product Code
0904-7113
Application Number
ANDA075873
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 28, 2021
MidazolamActive
Code: W7TTW573JJClass: ACTIMQuantity: 2 mg in 1 mL
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0LClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULRClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath